Enanta Pharmaceuticals Inc. (ENTA)
NASDAQ · Healthcare
Enanta Pharmaceuticals Inc. Cash on Hand 2020–2025
Enanta Pharmaceuticals Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Enanta Pharmaceuticals Inc. cash on hand as of September 30, 2025: 32.3M, a 13.25% decrease year-over-year.
- Enanta Pharmaceuticals Inc. cash on hand for 2025 were 32.3M, a 13.25% decrease from 2024.
- Enanta Pharmaceuticals Inc. cash on hand for 2024 were 37.2M, a 56.40% decrease from 2023.
- Enanta Pharmaceuticals Inc. cash on hand for 2023 were 85.4M, a 94.09% increase from 2022.
- Enanta Pharmaceuticals Inc. cash on hand for 2022 were 44.0M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Enanta Pharmaceuticals Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $32 |
| 2024 | $37 |
| 2023 | $85 |
| 2022 | $44 |
| 2021 | $57 |
| 2020 | $87 |
Enanta Pharmaceuticals Inc. Cash on Hand — FAQ
Enanta Pharmaceuticals Inc. (ENTA) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENTA's cash on hand history?
The chart and table above show Enanta Pharmaceuticals Inc.'s cash on hand by year and by quarter, including the growth rate.